Please wait...

Oliveboard

Govt Bans Ketoprofen and Aceclofenac to Save Vultures

Govt Bans Ketoprofen and Aceclofenac to Save Vultures

As per a notification released by the Union Ministry of Health and Family Welfare on July 31, 2023, the manufacturing, selling, and distribution of ‘ketoprofen’ and ‘aceclofenac’, which are harmful to vultures, along with their preparations, for use in animals are forbidden under section 26A of the Drugs and Cosmetics Act, 1940 (23 of 40).

The Drugs Technical Advisory Board (DTAB) proposed this prohibition.

What are Ketoprofen and Aceclofenac?

These drugs, known as non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used to alleviate pain and decrease inflammation in both humans and animals. However, these substances pose a threat to vultures and other types of birds of prey when they consume the remains of animals treated with these drugs.

Reasons Behind the Ban

Vultures in India

Vultures are birds of prey that come in medium to large sizes. Their distinct characteristic is their diet of carrion, which involves feeding on the remains of deceased animals.

In India, there are nine species of vultures. Among these, six are resident species, namely the white-rumped vulture, Indian vulture, slender-billed vulture, red-headed vulture, bearded vulture, and Egyptian vulture. Additionally, there are three migratory vulture species: the cinereous vulture, the griffon vulture, and the Himalayan vulture.

Conservation Initiatives

The National Board for Wildlife (NBWL) has given its approval to an Action Plan for Vulture Conservation from 2020 to 2025. Some key highlights of this plan are as follows:

These measures are part of a comprehensive strategy to safeguard vulture populations in India and mitigate the risks that have contributed to their decline.

About the Drugs Technical Advisory Board

The Drugs Technical Advisory Board (DTAB) is a statutory body constituted under the Drugs and Cosmetics Act, 1940. It is a part of the Central Drugs Standard Control Organization (CDSCO) in the Ministry of Health and Family Welfare. The DTAB is responsible for advising the Central Government and the State Governments on technical matters arising out of the administration of the Drugs and Cosmetics Act.